AAPL   267.01 (-2.38%)
MSFT   158.12 (-0.04%)
AMZN   1,842.20 (-2.23%)
CGC   18.00 (-2.39%)
NVDA   259.48 (+2.72%)
TSLA   636.60 (-6.24%)
F   6.79 (-2.58%)
AAPL   267.01 (-2.38%)
MSFT   158.12 (-0.04%)
AMZN   1,842.20 (-2.23%)
CGC   18.00 (-2.39%)
NVDA   259.48 (+2.72%)
TSLA   636.60 (-6.24%)
F   6.79 (-2.58%)
AAPL   267.01 (-2.38%)
MSFT   158.12 (-0.04%)
AMZN   1,842.20 (-2.23%)
CGC   18.00 (-2.39%)
NVDA   259.48 (+2.72%)
TSLA   636.60 (-6.24%)
F   6.79 (-2.58%)
AAPL   267.01 (-2.38%)
MSFT   158.12 (-0.04%)
AMZN   1,842.20 (-2.23%)
CGC   18.00 (-2.39%)
NVDA   259.48 (+2.72%)
TSLA   636.60 (-6.24%)
F   6.79 (-2.58%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TG TherapeuticsY-mAbs TherapeuticsDicerna PharmaceuticalsBELLUS HealthIntra-Cellular Therapies
SymbolNASDAQ:TGTXNASDAQ:YMABNASDAQ:DRNAOTCMKTS:BLUSFNASDAQ:ITCI
Price Information
Current Price$11.73$28.17$18.83N/A$20.21
52 Week RangeBuyBuyBuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$17.67$39.50$31.25N/A$37.75
% Upside from Price Target50.61% upside40.22% upside65.96% upsideN/A86.79% upside
Trade Information
Market Cap$1.38 billion$1.12 billion$1.39 billion$1.69 billion$1.14 billion
Beta2.551.132.631.552.09
Average Volume1,541,560142,108584,34061,933915,772
Sales & Book Value
Annual Revenue$150,000.00N/A$6.18 million$30,000.00$250,000.00
Price / Sales7,785.59N/A208.500.004,480.15
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.29 per share$4.11 per share$3.20 per share$0.25 per share$5.81 per share
Price / Book40.45N/A5.880.003.48
Profitability
Net Income$-173,480,000.00$-43,270,000.00$-88,850,000.00$-7,010,000.00$-155,130,000.00
EPSN/A($1.50)($1.20)N/A($2.84)
Trailing P/E Ratio0.00N/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-123,130.93%N/A-541.24%-49,910.34%N/A
Return on Equity (ROE)-2,411.79%-62.52%-58.92%-48.37%-54.27%
Return on Assets (ROA)-184.64%-55.17%-26.67%-45.25%-45.84%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.77%0.02%N/AN/A0.09%
Current Ratio1.00%7.12%2.68%13.87%7.77%
Quick Ratio1.00%7.12%2.68%13.87%7.77%
Ownership Information
Institutional Ownership Percentage58.40%48.60%84.03%N/A68.24%
Insider Ownership Percentage14.20%38.40%21.28%24.17%18.20%
Miscellaneous
Employees10532781073
Shares Outstanding99.56 million39.73 million68.43 million159.12 million55.42 million
Next Earnings Date3/3/2020 (Estimated)3/27/2020 (Estimated)5/14/2020 (Estimated)N/A3/2/2020 (Confirmed)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel